SEC Form 4 · accession 0001209191-18-059731
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
Nov 19, 2018
Accepted (ET)
Nov 21, 2018 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nov 19, 2018 | M | 31,483 | $2.40 | A | 577,553 | D | |
| Ordinary Shares | Nov 19, 2018 | M | 18,318 | $7.61 | A | 595,871 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.40 | Nov 19, 2018 | M | 31,483 | D | — | Jan 1, 2023 | Ordinary Shares | 31,483 | 107,187 | D |
| Stock Option (Right to Buy)F1 | $7.61 | Nov 19, 2018 | M | 18,318 | D | — | Jan 1, 2024 | Ordinary Shares | 18,318 | 204,682 | D |
Explanation of responses
- F1The stock option is fully vested and exercisable. The shares vested in 48 equal monthly installments following the grant date.